Articles citing this paper
Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study
Barbara de Graaff A , Amanda Neil A , Kristy Sanderson A , Kwang Chien Yee B and Andrew J. Palmer A C
+ Author Affiliations
- Author Affiliations
A Menzies Institute for Medical Research, Medical Science 2 Building, 17 Liverpool Street, Private Bag 23, University of Tasmania, Hobart, Tas. 7000, Australia. Email: Barbara.degraaff@utas.edu.au; Amanda.Neil@utas.edu.au; Kristy.Sanderson@utas.edu.au
B School of Medicine, Medical Science 1 Building, 17 Liverpool Street, Private Bag 68, University of Tasmania, Hobart, Tas. 7000, Australia. Email: Kwang.Yee@utas.edu.au
C Corresponding author. Email: Andrew.Palmer@utas.edu.au
Australian Health Review 41(3) 254-267 https://doi.org/10.1071/AH15188
Submitted: 12 October 2015 Accepted: 24 May 2016 Published: 22 July 2016
8 articles found in Crossref database.
Genetic hemochromatosis: Pathophysiology, diagnostic and therapeutic management
Brissot Pierre,
Cavey Thibault,
Ropert Martine,
Guggenbuhl Pascal, Loréal Olivier
La Presse Médicale. 2017 46(12). p.e288
Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model
de Graaff Barbara,
Si Lei,
Neil Amanda L.,
Yee Kwang Chien,
Sanderson Kristy,
Gurrin Lyle C., Palmer Andrew J.
PharmacoEconomics - Open. 2017 1(1). p.37
Healthcare expenditure and its socio-demographic and clinical predictors in Australians with poorly controlled asthma
Lartey Stella T.,
Lung Thomas,
Serhal Sarah,
Bereznicki Luke,
Bereznicki Bonnie,
Emmerton Lynne,
Bosnic-Anticevich Sinthia,
Saini Bandana,
Billot Laurent,
Krass Ines,
Armour Carol,
Jan Stephen, Ong Siew Chin
PLOS ONE. 2023 18(1). p.e0279748
Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review
Hoxha Malvina,
Malaj Visar, Zappacosta Bruno
PharmacoEconomics - Open. 2024 8(2). p.147
Health Care Utilization and Economic Burdens of Hemochromatosis in the United States: A Population-Based Claims Study
Elsaid Mohamed I.,
John Tina,
Li You,
Koduru Sobha,
Ali Saima Z.,
Catalano Carolyn,
Narayanan Navaneeth, Rustgi Vinod K.
Journal of Managed Care & Specialty Pharmacy. 2019 25(12). p.1377
Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia
de Graaff Barbara,
Neil Amanda,
Si Lei,
Yee Kwang Chien,
Sanderson Kristy,
Gurrin Lyle, Palmer Andrew J.
Applied Health Economics and Health Policy. 2017 15(4). p.521
Haemochromatosis patients' research priorities: Towards an improved quality of life
Romero‐Cortadellas Lídia,
Venturi Veronica,
Martín‐Sánchez Juan Carlos,
Toska Ketil,
Prince Dianne,
Butzeck Barbara,
Porto Graça,
Milman Nils Thorm,
Committee HI/EFAPH Survey, Sánchez Mayka
Health Expectations. 2023 26(6). p.2293
The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs
Ahmad Hasnat,
Campbell Julie A.,
van der Mei Ingrid,
Taylor Bruce V.,
Zhao Ting, Palmer Andrew J.
Multiple Sclerosis and Related Disorders. 2020 44 p.102247
